FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20471811000001105: Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1940861000001110 Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1940871000001117 Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has specific active ingredient Doxorubicin hydrochloride liposomal pegylated true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has active ingredient Doxorubicin true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Caelyx true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) 1 vial Has AMP True Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start